CVR 25507800Public limited company (A/S)Forskning og eksperimentel udvikling inden for naturvidenskab og teknik (721000)Nordlysvænget 10, 3000 HelsingørFounded 15 Jul 2000
BIO-Y A/S
Compiled by Dandex from the Danish Business Registry (CVR, datacvr.virk.dk), Erhvervsstyrelsen, and annual reports filed in XBRL. Values marked Dandex estimate are computed by Dandex from that data, not registered.
Dandex is Danish Company Data. Connect it once and ask about BIO-Y A/S, or any Danish company, from your assistant, the API or the command line. Answers come from the current record: owners and the ownership network, financials year by year, and the latest registered changes.
Set up DandexEmployees
1
CVR, Mar 2026
0 (0%) over 12 months
Gross profit
-43.7K
DKK, annual report 2024
Result
-1M
DKK, annual report 2024
Equity
-3.7M
DKK, annual report 2024
Holdingselskabet af 26. oktober 2023 ApSCVR 44418185, 50% to under 66.7% of capital and votes
Hamlet Investments Limited15% to under 20% of capital, 10% to under 15% of votes
Operating company
Dandex estimate: 1 employee registered in 2026; status is not activePeter Minoruntil 16 Apr 2026
Owners of 5% or more. CVR registers shares in bands, not exact figures.
CVR 4441818550% to under 66.7% of capital and votessince 10 Nov 2023
15% to under 20% of capital, 10% to under 15% of votesnotified 28 May 2019since 30 Apr 2015
5% to under 10% of capital and votesnotified 5 Dec 20183 Dec 2018 to 28 May 2019
10% to under 15% of capital and votesnotified 22 Feb 201730 Apr 2015 to 28 May 2019
5% to under 10% of capital and votes1 Oct 2012 to 5 Jan 2016
5% to under 10% of capital and votesnotified 28 May 201930 Mar 2015 to 28 May 2019
5% to under 10% of capital and votesnotified 18 Feb 20226 Jan 2016 to 3 Feb 2022
CVR 3643873850% to under 66.7% of capital and votesnotified 10 Nov 202328 May 2019 to 10 Nov 2023
5% to under 10% of capital and votes23 Apr 2015 to 28 May 2019
5% to under 10% of capital and votes6 Mar 2019 to 28 May 2019
Ultimate controller
Holding in Holdingselskabet af 26. oktober 2023 ApS, since 26 Oct 2023
Holding company
Holdingselskabet af 26. oktober 2023 ApS
CVR 44418185Private limited company (ApS)
Holding in BIO-Y A/S, since 10 Nov 2023
This company
BIO-Y A/S
CVR 25507800
CVR lists no current officers for this company.
CVR records founders at incorporation. It does not record whether they are alive or still involved.
Mar 2026, monthly: 1 employee, 1 FTE
Arrow keys move through the periods, Home and End go to the first and the latest, Escape returns to the latest.
| Period | 2000 | 2001 | Aug 2018 | Sep 2018 | Oct 2018 | Nov 2018 | Dec 2018 | Jan 2019 | Feb 2019 | Mar 2019 | Apr 2019 | May 2019 | Jun 2019 | Jul 2019 | Aug 2019 | Sep 2019 | Oct 2019 | Nov 2019 | Dec 2019 | Jan 2020 | Feb 2020 | Mar 2020 | Apr 2020 | May 2020 | Jun 2020 | Jul 2020 | Aug 2020 | Sep 2020 | Oct 2020 | Nov 2020 | Dec 2020 | Jan 2021 | Feb 2021 | Mar 2021 | Apr 2021 | May 2021 | Jun 2021 | Jul 2021 | Aug 2021 | Sep 2021 | Oct 2021 | Nov 2021 | Dec 2021 | Jan 2022 | Feb 2022 | Mar 2022 | Apr 2022 | May 2022 | Jun 2022 | Jul 2022 | Aug 2022 | Sep 2022 | Oct 2022 | Nov 2022 | Dec 2022 | Jan 2023 | Feb 2023 | Mar 2023 | Apr 2023 | May 2023 | Jun 2023 | Jul 2023 | Aug 2023 | Sep 2023 | Oct 2023 | Nov 2023 | Dec 2023 | Jan 2024 | Feb 2024 | Mar 2024 | Apr 2024 | May 2024 | Jun 2024 | Jul 2024 | Aug 2024 | Sep 2024 | Oct 2024 | Nov 2024 | Dec 2024 | Jan 2025 | Feb 2025 | Mar 2025 | Apr 2025 | May 2025 | Jun 2025 | Jul 2025 | Aug 2025 | Sep 2025 | Oct 2025 | Nov 2025 | Dec 2025 | Jan 2026 | Feb 2026 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Employees | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| FTE | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Series | Annual | Annual | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly |
The legal entity's headcount in CVR, not the annual report's average, which may cover a group. CVR changed its monthly method in Oct 2019: a step there need not be real.
Source: CVR, latest Mar 2026, published 20 May 2026.
The company's own figures, in DKK, from the annual reports filed in XBRL.
2024, DKK: Gross profit -43.7K, Operating profit -1.1M, Result for the year -1M
Arrow keys move through the years, Home and End go to the first and the latest, Escape returns to the latest.
2024, DKK: Total assets 2.1M, Equity -3.7M
Arrow keys move through the years, Home and End go to the first and the latest, Escape returns to the latest.
| DKK thousands | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Gross profit | -69 | -39 | -51 | -40 | -44 |
| Operating profit | -685 | -582 | -1,618 | -824 | -1,107 |
| Result for the year | -696 | -502 | -1,390 | -783 | -1,013 |
| Equity | -3,654 | -4,156 | -4,546 | -2,704 | -3,717 |
| Total assets | 2,353 | 1,739 | 1,218 | 3,228 | 2,050 |
| Employees (average) | 1 | 1 | 1 | 1 | 1 |
Amounts in DKK. Cash price is per DKK 1 of nominal capital, which a share split does not move. Implied value is the whole capital after the step at its cash price, not a valuation.
| Date | Change | Cash price | Paid in | Implied value | Capital after |
|---|---|---|---|---|---|
| IncreaseCashPaid in 2,625,000, cash price 1.05, implied value 9,199,575 | 1.05 | 2,625,000 | 9,199,575 | 8,761,500 | |
| IncreaseCashPaid in 1,000,000, cash price 1.05, implied value 6,574,575 | 1.05 | 1,000,000 | 6,574,575 | 6,261,500 | |
| IncreaseCashPaid in 3,221,250, cash price 1.05, implied value 5,574,575 | 1.05 | 3,221,250 | 5,574,575 | 5,309,119 | |
| IncreaseCashPaid in 1,000,003, cash price 8.86, implied value 19,861,840 | 8.86 | 1,000,003 | 19,861,840 | 2,241,262 | |
| IncreaseCashPaid in 1,138,036, cash price 8.86, implied value 18,861,836 | 8.86 | 1,138,036 | 18,861,836 | 2,128,419 | |
| IncreaseDebt conversion, to cover lossesPaid in 2,378,800 | None | 2,378,800 | None | 2,000,000 | |
| IncreaseCashPaid in 108,200 | None | 108,200 | None | 785,800 | |
| IncreaseCashPaid in 319,500, cash price 7.50, implied value 5,082,000 | 7.50 | 319,500 | 5,082,000 | 677,600 |
| Date | Change | Cash price | Paid in | Implied value | Capital after |
|---|---|---|---|---|---|
| IncreaseCash, debt conversionPaid in 605,650, cash price 6.69, implied value 4,246,563 | 6.69 | 605,650 | 4,246,563 | 635,000 | |
| FoundingNot read from the announcement | None | None | None | 500,000 |
Source: Erhvervsstyrelsen's announcements, shown where the amounts add up to the registered capital.
Pro: Signals (signaler) are in the Pro plan, see pricingChanges worth a look, raised from the registry and new annual reports.
New leadership (nyt lederskab), New company (ny virksomhed), Ownership change (ejerskifte), Relocation (flytning), Growth surge (vækstspurt), Headcount decline (nedgang i ansatte), Restructuring (omstrukturering), Industry change (brancheskift), Board change (bestyrelsesændring), Dissolution (ophør), Distress warning (risikoadvarsel), Fund investment (fondsinvestering), Fund exit (fondsexit), Fund board seat (fondsbestyrelsespost).
The company's own figures, in DKK, from the annual reports filed in XBRL.
| DKK thousands | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Gross profit growth (vækst i bruttofortjeneste) | -105.1% | n.m.note 1 | n.m.note 1 | n.m.note 1 | n.m.note 1 |
| EBITDA | -552 | -524 | -421 | -525 | -528 |
| EBITDA / gross profit (EBITDA i procent af bruttofortjenesten)Pro: EBITDA / gross profit (EBITDA i procent af bruttofortjenesten) is in the Pro plan, see pricingEBITDA as a share of gross profit. | Pro: EBITDA / gross profit (EBITDA i procent af bruttofortjenesten) is in the Pro plan, see pricingEBITDA as a share of gross profit. | ||||
| Employee growth (vækst i antal ansatte) | 0% | 0% | 0% | 0% | 0% |
| Net interest-bearing debt (NIBD, nettorentebærende gæld)Pro: Net interest-bearing debt (NIBD, nettorentebærende gæld) is in the Pro plan, see pricingInterest-bearing debt less cash and current securities; negative is net cash. | Pro: Net interest-bearing debt (NIBD, nettorentebærende gæld) is in the Pro plan, see pricingInterest-bearing debt less cash and current securities; negative is net cash. | ||||
| Gearing, NIBD / EBITDAPro: Gearing, NIBD / EBITDA is in the Pro plan, see pricingNet interest-bearing debt over EBITDA: the years of earnings the debt takes. | Pro: Gearing, NIBD / EBITDA is in the Pro plan, see pricingNet interest-bearing debt over EBITDA: the years of earnings the debt takes. | ||||
| Interest coverage (rentedækning)Pro: Interest coverage (rentedækning) is in the Pro plan, see pricingEBIT over finance expenses: how many times earnings cover the interest. | Pro: Interest coverage (rentedækning) is in the Pro plan, see pricingEBIT over finance expenses: how many times earnings cover the interest. | ||||
| Adjusted equity ratio (justeret soliditetsgrad)Pro: Adjusted equity ratio (justeret soliditetsgrad) is in the Pro plan, see pricingAdjusted equity as a share of total assets on the same basis. | Pro: Adjusted equity ratio (justeret soliditetsgrad) is in the Pro plan, see pricingAdjusted equity as a share of total assets on the same basis. | ||||
| ROIC (afkast af investeret kapital)Pro: ROIC (afkast af investeret kapital) is in the Pro plan, see pricingReturn on invested capital: EBIT after tax over equity plus net debt. | Pro: ROIC (afkast af investeret kapital) is in the Pro plan, see pricingReturn on invested capital: EBIT after tax over equity plus net debt. | ||||
| Capex (investeringer i anlægsaktiver) | 133note 2 | 58note 2 | 1,197note 2 | 300note 2 | 578note 2 |
| Capex % of sales (investeringer i procent af omsætningen)Pro: Capex % of sales (investeringer i procent af omsætningen) is in the Pro plan, see pricingCapex as a share of revenue. | Pro: Capex % of sales (investeringer i procent af omsætningen) is in the Pro plan, see pricingCapex as a share of revenue. | ||||
| FCFF / EBITDA (pengestrømskonvertering)Pro: FCFF / EBITDA (pengestrømskonvertering) is in the Pro plan, see pricingFree cash flow to the firm as a share of EBITDA. | Pro: FCFF / EBITDA (pengestrømskonvertering) is in the Pro plan, see pricingFree cash flow to the firm as a share of EBITDA. | ||||
Credit metrics are Dandex calculations, not filed values; grey figures are estimates with a note. Definitions. Revenue-based rows are empty: the company reports gross profit only (bruttofortjeneste), which class B filers may.
How each credit metric is calculated:
Decided by Dandex from CVR and the filed annual reports, not registered by the company.
Fixed rules decide most of these. The auditor's report, the business model, the revenue model and the activity in its own words are read by a calibrated decision model from the report's text and the purpose clause. Each label links to its definition.
Source: CVR, read 20 Nov 2026.
30 registrations, as published by Erhvervsstyrelsen. People's street addresses are cut to postcode and city.
Binavne:
GENOMICS A/S UNDER TVANGSOPLØSNING
Konkursdekret afsagt 27.08.2026 af Skifteretten i Helsingør
Likvidatorer:
Fratrådte:
Søren Pihl Hansen, den 27.08.2026.
Revision:
Likvidatorer:
Tiltrådte:
Skifteretten i Helsingør har udnævnt følgende likvidatorer: Søren Pihl Hansen, 3000 Helsingør, den 01.07.2026.
Virksomheden tegnes af en likvidator
Virksomhedens kreditorer opfordres til at anmelde deres krav til likvidator. Krav skal anmeldes senest tre måneder fra dags dato.
Anmodning om opløsning, jf. selskabslovens § 225 sendt til Skifteretten i Helsingør den 19.05.2026
Revision:
Fratrådte:
WILLADS & VIBE-HASTRUP GODKENDTE REVISORER ApS, den 17.04.2026.
Bestyrelse:
Fratrådte:
Daniel Bøøk Bonnichsen, den 16.04.2026, Anker Ernst Kreiels Ekelund, den 16.04.2026, Benny Villars Vittrup Jensen, den 16.04.2026, Jens Schaumann, (formand), den 16.04.2026.
Direktion:
Fratrådte:
Peter Minor, den 16.04.2026.
Vedtægter ændret: 28.09.2023
Kapitalforhøjelsen er besluttet den 28.09.2023.
kr. 2.500.000,00, indbetalt kontant, kurs 105,00.
Kapitalen udgør herefter kr. 8.761.499,95.
Vedtægter ændret: 03.02.2022
Kapitalforhøjelsen er besluttet den 03.02.2022.
kr. 952.380,95, indbetalt kontant, kurs 105,00.
Kapitalen udgør herefter kr. 6.261.499,95.
Vedtægter ændret: 25.06.2019
Kapitalforhøjelsen er besluttet den 25.06.2019.
kr. 3.067.857,00, indbetalt kontant, kurs 105,00.
Kapitalen udgør herefter kr. 5.309.119,00.
Bestyrelse:
Fratrådte:
Jens Schaumann, den 01.05.2019, Geoffrey Llewellyn Carter, (formand), den 01.05.2019.
Tiltrådte:
Jens Schaumann, (formand), den 01.05.2019.
Vedtægter ændret: 11.07.2018
Kapitalforhøjelsen er besluttet den 11.07.2018.
kr. 112.843,00, indbetalt kontant, kurs 886,19.
Kapitalen udgør herefter kr. 2.241.262,00.
Bestyrelse:
Fratrådte:
Peter Minor, den 12.09.2017, Ole Frands Sigetty (formand), den 12.09.2017, Geoffrey Llewellyn Carter, den 15.09.2017.
Tiltrådte:
Anker Ernst Kreiels Ekelund, den 12.09.2017, Jens Schaumann, den 12.09.2017, Geoffrey Llewellyn Carter (formand), den 15.09.2017.
Direktion:
Fratrådte:
Anker Ernst Kreiels Ekelund, den 12.09.2017.
Vedtægter ændret: 22.02.2017
Kapitalforhøjelsen er besluttet den 22.02.2017.
kr. 128.419,00, indbetalt kontant, kurs 886,19.
Kapitalen udgør herefter kr. 2.128.419,00.
Bestyrelse:
Fratrådte:
Anker Ernst Kreiels Ekelund, den 22.02.2017.
Tiltrådte:
Daniel Bøøk Bonnichsen, den 22.02.2017, Geoffrey Llewellyn Carter, den 22.02.2017.
Direktion:
Fratrådte:
.
Ny adresse: c/o Willads & Vibe-Hastrup, Nordlysvænget 10A, 3000 Helsingør
Ny adresse:
c/o Willads & Vibe-Hastrup, Trækbanen 8, 1., 3000 Helsingør.
Bestyrelse:
Udtrådt af bestyrelsen:
Kai Frode Christensen, den 22.07.2013.
Indtrådt i bestyrelsen:
Peter Minor, den 22.07.2013.
Vedtægter ændret:
18.09.2012.
Kapitalforhøjelse:
kr. 2.000.000,00 indbetalt ved konvertering af gæld, kurs 118,94.
Kapitalnedsættelse besluttet 18.09.2012 og gennemført 20.09.2012 dækning af underskud kr. 785.800,00 til kurs 100,00.
Kapitalen udgør herefter kr. 2.000.000,00.
Vedtægter ændret:
17.02.2005.
Vedtægter ændret:
17.02.2005.
Nyt navn:
BIO-Y A/S.
Nyt binavn: GENOMICS A/S (BIO-Y A/S).
Vedtægter ændret:
11.05.2004.
Kapitalforhøjelse:
kr. 108.200,00 indbetalt kontant, kurs 100,00.
Kapitalen udgør herefter kr. 785.800,00.
Ny adresse:
Strandgade 95, 3000 Helsingør.
Vedtægter ændret:
12.11.2003.
Kapitalforhøjelse:
kr. 42.600,00 indbetalt kontant, kurs 750,00.
Kapitalen udgør herefter kr. 677.600,00.
Bestyrelse:
Udtrådt af bestyrelsen:
Tom Barthel Hansen, den 01.12.2001.
Indtrådt i bestyrelsen:
Direktør Kai Frode Christensen, den 01.12.2001.
Direktion:
Udtrådt af direktionen:
Tom Barthel Hansen, den 01.12.2001.
Indtrådt i direktionen:
Direktør Anker Ernst Kreiels Ekelund.
Vedtægter ændret:
27.03.2001.
Ny adresse:
Stengade 53 B, 3000 Helsingør.
Ny kommune:
Helsingør.
Kapitalforhøjelse kr. 135.000,00: kr. 70.000,00 indbetalt kontant, kurs 750,00, kr. 10.000,00 indbetalt kontant, kurs 100,00, kr. 50.000,00 indbetalt ved konvertering af gæld, kurs 100,00, kr. 5.000,00 indbetalt ved konvertering af gæld, kurs 413,00.
Kapitalen udgør herefter kr. 635.000,00.
Vedtægter ændret:
18.08.2000.
Nyt navn:
GENOMICS A/S.
Ny adresse:
c/o Adv. Ole Sigetty, Frederiksgade 21, 1265 København K.
Bestyrelse:
Udtrådt af bestyrelsen:
Britta Madsen, den 18.08.2000, Vera Lykkesborg Petersen, den 18.08.2000, Steen Schierbeck, den 18.08.2000.
Indtrådt i bestyrelsen:
Anker Ernst Kreiels Ekelund, den 18.08.2000, Tom Barthel Hansen, den 18.08.2000, Advokat Ole Frands Sigetty, den 18.08.2000.
Direktion:
Udtrådt af direktionen:
Steen Schierbeck, den 18.08.2000.
Indtrådt i direktionen:
Tom Barthel Hansen, den 18.08.2000.
Selskabet tegnes af bestyrelsesformanden og et andet medlem af bestyrelsen i forening eller af bestyrelsesformanden og en direktør i forening eller af en direktør alene.
Revision:
Udtrådt af revisionen:
Carl Edvard Gudbergsen, den 18.08.2000.
Indtrådt i revisionen:
NY-Revision, 4700 Næstved, den 18.08.2000.
Stiftelsesdato:
15.07.2000.
Seneste vedtægtsdato:
15.07.2000.
Kapital:
kr. 500.000,00.
Indbetalingsmåde:
kontant kr. 500.000,00 til kurs 100,00.
Stifter:
CVR-NR. 10139597 ASX 9667 ApS, c/o Steen Schierbeck Advokatfirma, Store Kongensgade 118, 1264 København K, den 15.07.2000.
Bestyrelse:
Advokatsekretær Britta Madsen, den 15.07.2000, Advokatsekretær Vera Lykkesborg Petersen, den 15.07.2000, Advokat Steen Schierbeck, den 15.07.2000.
Direktion:
Advokat Steen Schierbeck, den 15.07.2000.
Selskabet tegnes af en direktør eller af den samlede bestyrelse.
Revision:
Statsaut. revisor Carl Edvard Gudbergsen, 2600 Glostrup, den 15.07.2000.
Første regnskabsår:
15.07.2000 - 31.12.2001.
Regnskabsår:
01.01 - 31.12.
Counts include corrections, and an audit firm that re-registered under a new entity.
Source: CVR, read 20 Nov 2026.
What Pro holds for BIO-Y A/S:
Have Pro? Sign in.
P-number 1007787797Stengade 53, 3000 Helsingør
P-number 1010502329Nordlysvænget 10, 3000 Helsingør